AMMI Canada - CACMID Annual Conference
25th ECCMID 2015
Mayo Clinic Infectious Diseases Subspecialties Update
HIV Management 2015: The New York Course
Find Practice Guidelines
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
IDSA Provides Testimony in Support of Supplemental Funding for Ebola Preparedness and Response Efforts
IDSA voiced support for the President’s emergency funding request to Congress to address Ebola and has also volunteered to lend its expertise and resources to aid in the U.S. and global response to the outbreak in a communication to Ebola Czar, Ron Klain.
IDSA, PIDS, and HIVMA Comments on NIH Physician-Scientist Workforce Report
IDSA, along with PIDS and HIVMA, jointly commented on the NIH Physician-Scientist Workforce Working Group report highlighting recommendations to improve the state of the physician-scientist workforce.
IDSA President Provides Testimony on the Need for New Antibiotics
On September 19th,
IDSA President Barbara Murray provided testimony to the Health Subcommittee of
the House Energy & Commerce Committee on the need for a coordinated federal
strategy to spur research and development for new antibiotics.
Tell Congress #CutsHurt!
Your help is needed to send a strong message to Congress that federal agency and program funding levels need to be finalized in the weeks ahead, so that new cuts are not set into motion.
Take Three Minutes to Support Antibiotic Development
Urge Congress to help speed patient access to the most urgently needed new antibacterial drugs.
IDSA Members Call on Congress to Advance LPAD Pathway
IDSA members answered a request from the House Energy and Commerce Committee on proposals to spur drug research and development.
The STAAR Act was reintroduced by Sen. Sherrod Brown this week. The bill, championed by IDSA, provides stronger federal leadership to coordinate activities that address resistance and strengthen accountability.
IDSA Applauds President’s Commitment to Combatting Antibiotic Resistance in FY 2015 Budget, Dismayed by Related Reductions
President Obama’s Fiscal Year 2015 budget includes a request to more than double funding for the CDC to combat antibiotic resistance, in addition to requests to fund efforts to track, prevent and control antibiotic resistance in the U.S. and around the world.
1 of 8
FDA approves Gardasil 9 for prevention of HPV
Dietary Supplements Containing Live Bacteria or Yeast in Immunocompromised Persons: Warning - Risk of Invasive Fungal Disease
Drifted Influenza A H3N2 Viruses: Reminder to vaccinate and consider antiviral medications
Fungal Contamination of Probiotic
>> Read More
For frail older adults living in long-term care facilities, the high-dose influenza vaccine appears to be a better option than the regular shot.
Legislation to establish a new limited population antibacterial drug approval pathway for antibacterial drugs to treat serious or life-threatening infections where there exists an unmet medical need.
A recent report from the Centers for Disease Control and Prevention (CDC) finds that the predominant circulating H3N2 influenza virus in the US has mutated, or drifted, from the corresponding vaccine strain.
In this issue:President's MessageReports from IDWeek 2014IDWeek Post Meeting Resources2014 Society Award Winners
In this issue:
Analyzing a patient’s breath for key compounds
may help detect invasive aspergillosis, a new CID study finds.
IDSA President, Dr. Barbara Murray testifies before the
House Energy & Commerce Committee on the urgency of fighting Antimicrobial
1 of 7
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2014 Infectious Diseases Society of America